Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
GRANIX is indicated to reduce the duration of severe neutropenia in adult and pediatric patients 1 month and older with non-myeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia.
- generic_name
- tbo-filgrastim
- product_names
- tbo-filgrastim
- ndc
- 63459-910, 63459-910-01, 63459-910-12, 63459-910-11, 63459-910-15, 63459-910-18, 63459-910-17, 63459-910-36, 63459-912, 63459-912-01, 63459-912-12, 63459-912-11, 63459-912-15, 63459-912-18, 63459-912-17, 63459-912-36, 63459-918, 63459-918-53, 63459-918-59, 63459-920, 63459-920-53, 63459-920-59
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en